Remarkably, the combination of ICI therapy not only reversed arthritis suppression but also underscored its dual impact on both cancer and immune response; gene expression analysis revealed a marked upregulation in interferon-alpha/beta receptor subunit 1 (Ifnar1) expression in the joints of mice with tumors treated with ICIs compared to controls. The gene discussed is IFNAR1; the disease is arthritic joint disease.